1
|
Akintobi TH, Barrett R, Hoffman L, Scott S, Davis K, Jones T, Brown NDV, Fraire M, Fraire R, Garner J, Gruner A, Hill J, Meckel R, Obi C, Omunga P, Parham Q, Rice T, Samples O, Terrill T. The community engagement course and action network: strengthening community and academic research partnerships to advance health equity. Front Public Health 2023; 11:1114868. [PMID: 37404270 PMCID: PMC10317472 DOI: 10.3389/fpubh.2023.1114868] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2022] [Accepted: 04/28/2023] [Indexed: 07/06/2023] Open
Abstract
Background Historically Black Colleges and Universities and Minority Serving Institutions are uniquely positioned to implement community-campus research partnerships based on a history of service, the pursuit of community trustworthiness and student demographics often similar to surrounding marginalized communities. The Morehouse School of Medicine Prevention Research Center collaborates with members of Historically Black Colleges and Universities, Minority Serving Institutes, and community organizations on the Community Engaged Course and Action Network. This network is the first of its kind and aims to strengthen members' ability to implement Community-Based Participatory Research (CBPR) principles and partnerships. Projects address public health priorities including mental health among communities of color, zoonotic disease prevention, and urban food deserts. Materials and methods To assess the effectiveness of the network, a Participatory Evaluation framework was implemented to conduct process evaluation which included review of partnership structures, operations, project implementation processes, and preliminary outcomes of the research collaborations. A focus group of Community Engagement Course and Action Network members (community and academic) was also conducted to identify benefits and challenges of the network with emphasis on key areas for improvement to further enhance the relationships between partners and to facilitate their subsequent community-campus research. Results Network improvements were tied to themes strengthening community-academic partnerships including sharing and fellowship, coalition building and collaboration, and greater connections and awareness of community needs through their current community-academic partnerships. The need to conduct ongoing evaluation during and after implementation, for determining the early adoption of CBPR approaches was also identified. Conclusion Evaluation of the network's processes, infrastructure, and operation provides early lessons learned to strengthen the network. Ongoing assessment is also essential for ensuring continuous quality improvement across partnerships such as determining CBPR fidelity, assessing partnership synergy, and dynamics, and for quality improvement of research protocol. The implications and potential for advancing implementation science through this and similar networks are great towards advancing leadership in modeling how foundations in community service can advance to CBPR partnership formation and ultimately, health equity approaches, that are local defined and assessed.
Collapse
Affiliation(s)
- Tabia Henry Akintobi
- Morehouse School of Medicine Prevention Research Center, Atlanta, GA, United States
| | - R. Barrett
- Morehouse School of Medicine Prevention Research Center, Atlanta, GA, United States
| | - L. Hoffman
- Morehouse School of Medicine Prevention Research Center Community Coalition Board, Atlanta, GA, United States
| | - S. Scott
- Morehouse School of Medicine Prevention Research Center, Atlanta, GA, United States
| | - K. Davis
- Morehouse School of Medicine Prevention Research Center, Atlanta, GA, United States
| | - T. Jones
- Morehouse School of Medicine Prevention Research Center, Atlanta, GA, United States
| | - N. De Veauuse Brown
- Georgia State University, School of Public Health, Atlanta, GA, United States
| | - M. Fraire
- Coalition of Latino Leaders (CLILA), Dalton, GA, United States
| | - R. Fraire
- Coalition of Latino Leaders (CLILA), Dalton, GA, United States
| | - J. Garner
- Georgia State University, School of Public Health, Atlanta, GA, United States
| | - A. Gruner
- Coalition of Latino Leaders (CLILA), Dalton, GA, United States
| | - J. Hill
- Georgia State University, School of Public Health, Atlanta, GA, United States
| | - R. Meckel
- Georgia Department of Natural Resources, Atlanta, GA, United States
| | - C. Obi
- Fort Valley State University College of Agriculture, Family Sciences and Technology, Fort Valley, GA, United States
| | - P. Omunga
- Savannah State University, Political Science and Public Affairs, Savannah, GA, United States
| | - Q. Parham
- Savannah State University, Political Science and Public Affairs, Savannah, GA, United States
| | - T. Rice
- Dalton State College Allied Health and Social Work, Dalton, GA, United States
| | - O. Samples
- Fort Valley State University College of Agriculture, Family Sciences and Technology, Fort Valley, GA, United States
| | - T. Terrill
- Fort Valley State University College of Agriculture, Family Sciences and Technology, Fort Valley, GA, United States
| |
Collapse
|
2
|
Hoffman L, Ingle P, Hemant Khole A, Zhang S, Yang Z, Beya M, Bureš D, Cozzolino D. Discrimination of lamb (Ovis aries), emu (Dromaius novaehollandiae), camel (Camelus dromedarius) and beef (Bos taurus) binary mixtures using a portable near infrared instrument combined with chemometrics. Spectrochim Acta A Mol Biomol Spectrosc 2023; 294:122506. [PMID: 36868023 DOI: 10.1016/j.saa.2023.122506] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/24/2022] [Revised: 02/07/2023] [Accepted: 02/13/2023] [Indexed: 06/18/2023]
Abstract
Consumers demand safe and nutritious foods at accessible prices; where issues associated with adulteration, fraud, and provenance have become important aspects to be considered by the modern food industry. There are many analytical techniques and methods available to determine food composition and quality, including food security. Among them, vibrational spectroscopy techniques are at the first line of defence (near and mid infrared spectroscopy, and Raman spectroscopy). In this study, a portable near infrared (NIR) instrument was evaluated to identify different levels of adulteration between binary mixtures of exotic and traditional meat species. Fresh meat cuts of lamb (Ovis aries), emu (Dromaius novaehollandiae), camel (Camelus dromedarius) and beef (Bos taurus) sourced from a commercial abattoir were used to make different binary mixtures (95 % %w/w, 90 % %w/w, 50 % %w/w, 10 % %w/w and 5 % %w/w) and analysed using a portable NIR instrument. The NIR spectra of the meat mixtures was analysed using principal component analysis (PCA), and partial least squares discriminant analysis (PLS-DA). Two isosbestic points corresponding to absorbances at 1028 nm and 1224 nm were found to be consistent across all the binary mixtures analysed. The coefficient of determination in cross validation (R2) obtained for the determination of the per cent of species in a binary mixture was above 90 % with a standard error in cross validation (SECV) ranging between 12.6 and 15 %w/w. Overall, the results of this study indicate that NIR spectroscopy can determine the level or ratio of adulteration in the binary mixtures of minced meat.
Collapse
Affiliation(s)
- L Hoffman
- The University of Queensland, Centre for Nutrition and Food Sciences (CNAFS), Queensland Alliance for Agriculture and Food Innovation (QAAFI), Brisbane, Queensland 4072, Australia
| | - P Ingle
- The University of Queensland, Centre for Nutrition and Food Sciences (CNAFS), Queensland Alliance for Agriculture and Food Innovation (QAAFI), Brisbane, Queensland 4072, Australia; The University of Queensland, School of Agriculture and Food Sciences, Brisbane, Queensland 4072, Australia
| | - A Hemant Khole
- The University of Queensland, Centre for Nutrition and Food Sciences (CNAFS), Queensland Alliance for Agriculture and Food Innovation (QAAFI), Brisbane, Queensland 4072, Australia; The University of Queensland, School of Agriculture and Food Sciences, Brisbane, Queensland 4072, Australia
| | - S Zhang
- The University of Queensland, Centre for Nutrition and Food Sciences (CNAFS), Queensland Alliance for Agriculture and Food Innovation (QAAFI), Brisbane, Queensland 4072, Australia; The University of Queensland, School of Agriculture and Food Sciences, Brisbane, Queensland 4072, Australia
| | - Z Yang
- The University of Queensland, Centre for Nutrition and Food Sciences (CNAFS), Queensland Alliance for Agriculture and Food Innovation (QAAFI), Brisbane, Queensland 4072, Australia; The University of Queensland, School of Agriculture and Food Sciences, Brisbane, Queensland 4072, Australia
| | - M Beya
- The University of Queensland, Centre for Nutrition and Food Sciences (CNAFS), Queensland Alliance for Agriculture and Food Innovation (QAAFI), Brisbane, Queensland 4072, Australia
| | - D Bureš
- Institute of Animal Science, 104 00 Přátelství 815, 104 00 Prague, Czech Republic; Department of Food Science, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences, Prague, 165 00 Prague, Czech Republic
| | - D Cozzolino
- The University of Queensland, Centre for Nutrition and Food Sciences (CNAFS), Queensland Alliance for Agriculture and Food Innovation (QAAFI), Brisbane, Queensland 4072, Australia.
| |
Collapse
|
3
|
Morris A, Yau Y, Howell P, Parsek M, Hoffman L, Nguyen D, Rooney A, Coburn B, McDonald N, DiGiandomenico A, Wozniak D, Waters V. 570 Visualization of Pseudomonas aeruginosa biofilms in sputum of children with cystic fibrosis who fail eradication therapy. J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)01260-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
4
|
Hayden H, Nelson M, Ross S, Vo A, Penewit K, Eng A, Salipante S, Hoffman L, Sanders D. 541 Effect of therapeutic antibiotic exposure on oropharyngeal and fecal microbiota in infants with cystic fibrosis. J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)01231-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
5
|
Békés V, Aafjes-Van Doorn K, Zilcha-Mano S, Prout T, Hoffman L. Psychotherapists’ Acceptance of Telepsychotherapy: A Machine Learning Approach. Eur Psychiatry 2022. [PMCID: PMC9567204 DOI: 10.1192/j.eurpsy.2022.447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Introduction Therapists’ forced transition to provide psychotherapy remotely during the COVID-19 pandemic offers a unique opportunity to examine therapists’ views and challenges with teletherapy. Objectives We aimed to develop predictive models of three aspects of psychotherapists’ acceptance of teletherapy during the COVID-19 pandemic; attitudes towards teletherapy, concerns about using teletherapy, and intention to use it in the future. Methods In an international survey, therapists (N = 795) completed a survey about their experiences during the pandemic, including quality of therapeutic relationship, professional self-doubt, vicarious trauma, and telepsychotherapy acceptance. Regression decision trees machine learning analyses were used to build prediction models for each aspects of telepsychotherapy acceptance. Results Attitudes toward telepsychotherapy were most positive for therapists who reported neutral or strong online working alliance, especially if they experienced little professional self-doubt and were younger than 40 years old. Therapists who were most concerned about telepsychotherapy, were those who reported higher levels of professional self-doubt, particularly if they also reported vicarious trauma experiences. Therapists who reported low working alliance were the least likely to use telepsychotherapy in the future. Conclusions Therapists’ professional self-doubt and the quality of their working alliance with their telepsychotherapy patients appear to be the most pertinent factors associated with therapists’ acceptance of telepsychotherapy during COVID-19, and should be addressed in future training and research. Disclosure No significant relationships.
Collapse
|
6
|
Blanchard A, Hewko S, Somayaji R, Cogen J, Hernandez R, Stephenson A, Yau Y, Julien J, Quon B, Downey D, Hoffman L, Waters V. 490: A prospective study to evaluate serologic and immune responses to SARS-COV-2 infection in persons living with cystic fibrosis: Canadian arm of the CAR-CF study. J Cyst Fibros 2021. [PMCID: PMC8518460 DOI: 10.1016/s1569-1993(21)01914-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
7
|
Gonsalves L, Dutta A, Waalkes A, Long D, Salipante S, Hoffman L, Wolter D. 476: Adaptive responses of Staphylococcus aureus to trimethoprim/sulfamethoxazole. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)01900-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
8
|
Henniger M, Sisson S, Wetherill M, Hoffman L, Macedo C, Williams B. Staff Reported Highest Rate of Food Insecurity at an Academic Health Campus in Oklahoma City, OK. J Acad Nutr Diet 2020. [DOI: 10.1016/j.jand.2020.06.095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
9
|
Gilpin D, Carson G, Hoffman L, Tunney M, Muhlebach M. ePS6.02 Does spa type play a role in establishment of chronic MRSA infection? J Cyst Fibros 2019. [DOI: 10.1016/s1569-1993(19)30288-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
10
|
Wolter D, Onchiri F, Emerson J, Precit M, Lee M, McNamara S, Nay L, Blackledge M, Uluer A, Mann M, Orenstein D, Hoover W, Burns J, Hoffman L. ePS6.01 Prevalence and clinical significance of Staphylococcus aureus smallcolony variants: a prospective longitudinal, multicentre study. J Cyst Fibros 2019. [DOI: 10.1016/s1569-1993(19)30287-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
11
|
Hargrave D, Witt O, Cohen K, Packer R, Lissat A, Kordes U, Laetsch T, Hoffman L, Lassaletta A, Gerber N, Gilheeney S, Holm S, Kramm C, Sumerauer D, Reitmann C, Russo M, Bouffet E. Phase II open-label, global study evaluating dabrafenib in combination with trametinib in pediatric patients with BRAF V600–mutant high-grade glioma (HGG) or low-grade glioma (LGG). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy273.395] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
12
|
Naghibosadat M, Lalonde T, Luyt L, Hoffman L, Dhanvantari S. GHRELIN AND DES-ACYL GHRELIN BINDING IN CARDIAC TISSUE ARE ALTERED WITH CARDIOVASCULAR INFLAMMATION IN DUCHENNE MUSCULAR DYSTROPHY. Can J Cardiol 2018. [DOI: 10.1016/j.cjca.2018.07.361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
13
|
Hoffman L, Tomalin L, Schultz G, Howell M, Anandasabapathy N, Alavi A, Suarezfarinas M, Lowes M. 457 Integrating the hidradenitis suppurativa skin transcriptome and serum proteome suggests complement activation and bacterial involvement in disease progression. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.464] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
14
|
Gilpin D, Torres-Bustos J, Carson G, Payne J, Hoffman L, O'Leary C, Muhlebach M. 106 Characterisation of MRSA from initial versus chronic infection in CF patients. J Cyst Fibros 2017. [DOI: 10.1016/s1569-1993(17)30470-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
15
|
Hoffman L, Hou A, Chaitowitz M, Lowes M, Cohen S. 235 Anemia in hidradenitits suppurativa. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.02.250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
16
|
Emhardt E, Siegel J, Hoffman L. Anatomic variation and orgasm: Could variations in anatomy explain differences in orgasmic success? Clin Anat 2016; 29:665-72. [PMID: 26916103 DOI: 10.1002/ca.22703] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2015] [Revised: 02/16/2016] [Accepted: 02/16/2016] [Indexed: 01/18/2023]
Abstract
Though the public consciousness is typically focused on factors such as psychology, penis size, and the presence of the "G-spot," there are other anatomical and neuro-anatomic differences that could play an equal, or more important, role in the frequency and intensity of orgasms. Discovering these variations could direct further medical or procedural management to improve sexual satisfaction. The aim of this study is to review the available literature of anatomical sexual variation and to explain why this variation may predispose some patients toward a particular sexual experience. In this review, we explored the available literature on sexual anatomy and neuro-anatomy. We used PubMed and OVID Medline for search terms, including orgasm, penile size variation, clitoral variation, Grafenberg spot, and benefits of orgasm. First we review the basic anatomy and innervation of the reproductive organs. Then we describe several anatomical variations that likely play a superior role to popular known variation (penis size, presence of g-spot, etc). For males, the delicate play between the parasympathetic and sympathetic nervous systems is vital to achieve orgasm. For females, the autonomic component is more complex. The clitoris is the primary anatomical feature for female orgasm, including its migration toward the anterior vaginal wall. In conclusions, orgasms are complex phenomena involving psychological, physiological, and anatomic variation. While these variations predispose people to certain sexual function, future research should explore how to surgically or medically alter these. Clin. Anat. 29:665-672, 2016. © 2016 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
- E Emhardt
- Class of 2016, Indiana University School of Medicine, Indianapolis, Indiana, 46220
| | - J Siegel
- Department of Neurology, Mayo Clinic, Jacksonville, Florida, 32224
| | - L Hoffman
- Department of Anatomy, Indiana University School of Medicine, Fort Wayne, Indiana, 46805
| |
Collapse
|
17
|
Griesinger A, Josephson R, Donson A, Levy JM, Amani V, Birks D, Hoffman L, Vibhakar R, Handler M, Foreman N. EP-04 * ACTIVATION OF THE IL6/STAT3 PATHWAY IN CHILDHOOD EPENDYMOMA IS ASSOCIATED WITH A PRO-INFLAMMATORY TUMOR MICROENVIRONMENT AND A POOR PROGNOSIS. Neuro Oncol 2015. [DOI: 10.1093/neuonc/nov061.23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
18
|
Affiliation(s)
- J Marco
- Facultad de Medicinia, Valencia, Spain
| | | | | | | |
Collapse
|
19
|
Haines A, Blazeck A, Hoffman L, Choi J, Spadaro K. A Randomized Controlled Trial to Assess the Effect of Mindfulness Based Stress Reduction (MBSR) on Stress and Anxiety in Caregivers of Lung Transplant Patients. J Heart Lung Transplant 2015. [DOI: 10.1016/j.healun.2015.01.663] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
20
|
Thøgersen E, Møller D, Hoffman L. PO-1112 Quantification of interfractional movement of the oesophagus and the influence on the dose to the oesophagus. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)41104-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
21
|
Hoffman LM, Donson AM, Nakachi I, Griesinger AM, Birks DK, Amani V, Hemenway MS, Liu AK, Wang M, Hankinson TC, Handler MH, Foreman NK, Zakrzewska M, Zakrzewski K, Fendler W, Stefanczyk L, Liberski PP, Massimino M, Gandola L, Ferroli P, Valentini L, Biassoni V, Garre ML, Sardi I, Genitori L, Giussani C, Massimi L, Bertin D, Mussano A, Viscardi E, Modena P, Mastronuzzi A, Barra S, Scarzello G, Cinalli G, Peretta P, Giangaspero F, Massimino M, Boschetti L, Biassoni V, Garre ML, Schiavello E, Sardi I, Genitori L, Bertin D, Modena P, Calareso G, Barra S, Scarzello G, Cinalli G, Peretta P, Mastronuzzi A, Giussani C, Giangaspero F, Antonelli M, Pecori E, Gandola L, Massimino M, Biassoni V, Di Meco F, Garre ML, Schiavello E, Sardi I, Genitori L, Bertin D, Viscardi E, Modena P, Barra S, Scarzello G, Cinalli G, Peretta P, Migliorati R, Taborelli A, Giangaspero F, Antonelli M, Pecori E, Gandola L, Witt H, Sill M, Wani K, Mack SC, Capper D, Pajtler K, Lambert S, Tzaridis T, Milde T, Northcott PA, Kulozik AE, Witt O, Collins VP, Ellison DW, Taylor MD, Kool M, Jones DTW, Korshunov A, Ken A, Pfister SM, Makino K, Nakamura H, Kuroda JI, Kuratsu JI, Toledano H, Margolin Y, Ohali A, Michowiz S, Witt H, Johann P, Tzaridis T, Tabori U, Walker E, Hawkins C, Taylor M, Yaniv I, Avigad S, Hoffman L, Plimpton SR, Foreman NK, Stence NV, Hankinson TC, Handler MH, Hemenway MS, Vibhakar R, Liu AK, Lourdusamy A, Rahman R, Ward J, Rogers H, Grundy R, Punchihewa C, Lee R, Lin T, Orisme W, Dalton J, Aronica E, Smith A, Gajjar A, Onar A, Pounds S, Tatevossian R, Merchant T, Ellison D, Parker M, Mohankumar K, Punchihewa C, Weinlich R, Dalton J, Tatevossian R, Phoenix T, Thiruvenkatam R, White E, Gupta K, Gajjar A, Merchant T, Boop F, Smith A, Ding L, Mardis E, Wilson R, Downing J, Ellison D, Gilbertson R, Ward J, Lourdusamy A, Speed D, Gould T, Grundy R, Rahman R, Mack SC, Witt H, Pfister SM, Korshunov A, Taylor MD, Consortium TIE, Hoffman LM, Griesinger A, Donson A, Birks D, Amani V, Foreman NK, Ohe N, Yano H, Nakayama N, Iwama T, Wright K, Hassall T, Bowers DC, Crawford J, Bendel A, Fisher PG, Merchant T, Ellison D, Klimo P, Boop F, Armstrong G, Qaddoumi I, Robinson G, Wetmore C, Broniscer A, Gajjar A, Rogers H, Chapman R, Mayne C, Duane H, Kilday JP, Coyle B, Grundy R, Graul-Conroy A, Hartsell W, Bragg T, Goldman S, Rebsamen S, Puccetti D, Salamat S, Patel NJ, Gomi A, Oguma H, Hayase T, Kawahara Y, Yagi M, Morimoto A, Wilbur C, Dunham C, Hawkins C, Tabori U, Mabbott D, Carret AS, Lafay-Cousin L, McNeely PD, Eisenstat D, Wilson B, Johnston D, Hukin J, Mynarek M, Kortmann RD, Kaatsch P, Pietsch T, Timmermann B, Fleischhack G, Benesch M, Friedrich C, von Bueren AO, Gerber NU, Muller K, Tippelt S, Warmuth-Metz M, Rutkowski S, von Hoff K, Murugesan MK, White E, Poppleton H, Thiruvenkatam R, Gupta K, Currle S, Kranenburg T, Eden C, Wright K, Ellison D, Gilbertson R, Boulos N, Dapper J, Patel Y, Wright K, Mohankumar K, Freeman B, Gajjar A, Shelat A, Stewart C, Guy R, Gilbertson R, Adamski J, Taylor M, Tabori U, Huang A, Bartels U, Ramaswamy V, Krishnatry R, Laperriere N, Hawkins C, Bouffet E, Araki A, Chocholous M, Gojo J, Dorfer C, Czech T, Dieckmann K, Slavc I, Haberler C, Pietsch T, Mynarek M, Doerner E, Muehlen AZ, Warmuth-Metz M, Kortmann R, von Buehren A, Friedrich C, von Hoff K, Rutkowski S, von Hoff K, Kortmann RD, Gerber NU, Mynarek M, Muller K, Friedrich C, von Bueren AO, Benesch M, Warmuth-Metz M, Ottensmeier H, Resch A, Kwiecien R, Faldum A, Kuehl J, Pietsch T, Rutkowski S, Sabnis D, Storer L, Simmonds L, Blackburn S, Lowe J, Grundy R, Kerr I, Coyle B, Pietsch T, Wohlers I, Goschzik T, Dreschmann V, Denkhaus D, Doerner E, Rahmann S, Klein-Hitpass L, Iglesias MJL, Riet FG, Dhermain FD, Canale S, Dufour C, Rose CS, Puget S, Grill J, Bolle S, Parkes J, Davidson A, Figaji A, Pillay K, Kilborn T, Padayachy L, Hendricks M, Van Eyssen A, Piccinin E, Lorenzetto E, Brenca M, Massimino M, Modena P, Taylor M, Ramaswamy V, Bouffet E, Aldape K, Cho YJ, Weiss W, Phillips J, Jabado N, Mora J, Fan X, Jung S, Lee JY, Zitterbart K, French P, Kros JM, Hauser P, Faria C, Korshunov A, Pfister S, Mack SC. EPENDYMOMA. Neuro Oncol 2014; 16:i17-i25. [PMCID: PMC4046284 DOI: 10.1093/neuonc/nou068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/07/2023] Open
|
22
|
Adachi K, Sasaki H, Nagahisa S, Yoshida K, Hattori N, Nishiyama Y, Kawase T, Hasegawa M, Abe M, Hirose Y, Alentorn A, Marie Y, Poggioli S, Alshehhi H, Boisselier B, Carpentier C, Mokhtari K, Capelle L, Figarella-Branger D, Hoang-Xuan K, Sanson M, Delattre JY, Idbaih A, Yust-Katz S, Anderson M, Olar A, Eterovic A, Ezzeddine N, Chen K, Zhao H, Fuller G, Aldape K, de Groot J, Andor N, Harness J, Lopez SG, Fung TL, Mewes HW, Petritsch C, Arivazhagan A, Somasundaram K, Thennarasu K, Pandey P, Anandh B, Santosh V, Chandramouli B, Hegde A, Kondaiah P, Rao M, Bell R, Kang R, Hong C, Song J, Costello J, Bell R, Nagarajan R, Zhang B, Diaz A, Wang T, Song J, Costello J, Bie L, Li Y, Li Y, Liu H, Luyo WFC, Carnero MH, Iruegas MEP, Morell AR, Figueiras MC, Lopez RL, Valverde CF, Chan AKY, Pang JCS, Chung NYF, Li KKW, Poon WS, Chan DTM, Wang Y, Ng HAK, Chaumeil M, Larson P, Yoshihara H, Vigneron D, Nelson S, Pieper R, Phillips J, Ronen S, Clark V, Omay ZE, Serin A, Gunel J, Omay B, Grady C, Youngblood M, Bilguvar K, Baehring J, Piepmeier J, Gutin P, Vortmeyer A, Brennan C, Pamir MN, Kilic T, Krischek B, Simon M, Yasuno K, Gunel M, Cohen AL, Sato M, Aldape KD, Mason C, Diefes K, Heathcock L, Abegglen L, Shrieve D, Couldwell W, Schiffman JD, Colman H, D'Alessandris QG, Cenci T, Martini M, Ricci-Vitiani L, De Maria R, Larocca LM, Pallini R, de Groot J, Theeler B, Aldape K, Lang F, Rao G, Gilbert M, Sulman E, Luthra R, Eterovic K, Chen K, Routbort M, Verhaak R, Mills G, Mendelsohn J, Meric-Bernstam F, Yung A, MacArthur K, Hahn S, Kao G, Lustig R, Alonso-Basanta M, Chandrasekaran S, Wileyto EP, Reyes E, Dorsey J, Fujii K, Kurozumi K, Ichikawa T, Onishi M, Ishida J, Shimazu Y, Kaur B, Chiocca EA, Date I, Geisenberger C, Mock A, Warta R, Schwager C, Hartmann C, von Deimling A, Abdollahi A, Herold-Mende C, Gevaert O, Achrol A, Gholamin S, Mitra S, Westbroek E, Loya J, Mitchell L, Chang S, Steinberg G, Plevritis S, Cheshier S, Gevaert O, Mitchell L, Achrol A, Xu J, Steinberg G, Cheshier S, Napel S, Zaharchuk G, Plevritis S, Gevaert O, Achrol A, Chang S, Harsh G, Steinberg G, Cheshier S, Plevritis S, Gutman D, Holder C, Colen R, Dunn W, Jain R, Cooper L, Hwang S, Flanders A, Brat D, Hayes J, Droop A, Thygesen H, Boissinot M, Westhead D, Short S, Lawler S, Bady P, Kurscheid S, Delorenzi M, Hegi ME, Crosby C, Faulkner C, Smye-Rumsby T, Kurian K, Williams M, Hopkins K, Faulkner C, Palmer A, Williams H, Wragg C, Haynes HR, Williams M, Hopkins K, Kurian KM, Haynes HR, Crosby C, Williams H, White P, Hopkins K, Williams M, Kurian KM, Ishida J, Kurozumi K, Ichikawa T, Onishi M, Fujii K, Shimazu Y, Oka T, Date I, Jalbert L, Elkhaled A, Phillips J, Chang S, Nelson S, Jensen R, Salzman K, Schabel M, Gillespie D, Mumert M, Johnson B, Mazor T, Hong C, Barnes M, Yamamoto S, Ueda H, Tatsuno K, Aihara K, Jalbert L, Nelson S, Bollen A, Hirst M, Marra M, Mukasa A, Saito N, Aburatani H, Berger M, Chang S, Taylor B, Costello J, Popov S, Mackay A, Ingram W, Burford A, Jury A, Vinci M, Jones C, Jones DTW, Hovestadt V, Picelli S, Wang W, Northcott PA, Kool M, Reifenberger G, Pietsch T, Sultan M, Lehrach H, Yaspo ML, Borkhardt A, Landgraf P, Eils R, Korshunov A, Zapatka M, Radlwimmer B, Pfister SM, Lichter P, Joy A, Smirnov I, Reiser M, Shapiro W, Mills G, Kim S, Feuerstein B, Jungk C, Mock A, Geisenberger C, Warta R, Friauf S, Unterberg A, Herold-Mende C, Juratli TA, McElroy J, Meng W, Huebner A, Geiger KD, Krex D, Schackert G, Chakravarti A, Lautenschlaeger T, Kim BY, Jiang W, Beiko J, Prabhu S, DeMonte F, Lang F, Gilbert M, Aldape K, Sawaya R, Cahill D, McCutcheon I, Lau C, Wang L, Terashima K, Yamaguchi S, Burstein M, Sun J, Suzuki T, Nishikawa R, Nakamura H, Natsume A, Terasaka S, Ng HK, Muzny D, Gibbs R, Wheeler D, Lautenschlaeger T, Juratli TA, McElroy J, Meng W, Huebner A, Geiger KD, Krex D, Schackert G, Chakravarti A, Zhang XQ, Sun S, Lam KF, Kiang KMY, Pu JKS, Ho ASW, Leung GKK, Loebel F, Curry WT, Barker FG, Lelic N, Chi AS, Cahill DP, Lu D, Yin J, Teo C, McDonald K, Madhankumar A, Weston C, Slagle-Webb B, Sheehan J, Patel A, Glantz M, Connor J, Maire C, Francis J, Zhang CZ, Jung J, Manzo V, Adalsteinsson V, Homer H, Blumenstiel B, Pedamallu CS, Nickerson E, Ligon A, Love C, Meyerson M, Ligon K, Mazor T, Johnson B, Hong C, Barnes M, Jalbert LE, Nelson SJ, Bollen AW, Smirnov IV, Song JS, Olshen AB, Berger MS, Chang SM, Taylor BS, Costello JF, Mehta S, Armstrong B, Peng S, Bapat A, Berens M, Melendez B, Mollejo M, Mur P, Hernandez-Iglesias T, Fiano C, Ruiz J, Rey JA, Mock A, Stadler V, Schulte A, Lamszus K, Schichor C, Westphal M, Tonn JC, Unterberg A, Herold-Mende C, Morozova O, Katzman S, Grifford M, Salama S, Haussler D, Nagarajan R, Zhang B, Johnson B, Bell R, Olshen A, Fouse S, Diaz A, Smirnov I, Kang R, Wang T, Costello J, Nakamizo S, Sasayama T, Tanaka H, Tanaka K, Mizukawa K, Yoshida M, Kohmura E, Northcott P, Hovestadt V, Jones D, Kool M, Korshunov A, Lichter P, Pfister S, Otani R, Mukasa A, Takayanagi S, Saito K, Tanaka S, Shin M, Saito N, Ozawa T, Riester M, Cheng YK, Huse J, Helmy K, Charles N, Squatrito M, Michor F, Holland E, Perrech M, Dreher L, Rohn G, Goldbrunner R, Timmer M, Pollo B, Palumbo V, Calatozzolo C, Patane M, Nunziata R, Farinotti M, Silvani A, Lodrini S, Finocchiaro G, Lopez E, Rioscovian A, Ruiz R, Siordia G, de Leon AP, Rostomily C, Rostomily R, Silbergeld D, Kolstoe D, Chamberlain M, Silber J, Roth P, Keller A, Hoheisel J, Codo P, Bauer A, Backes C, Leidinger P, Meese E, Thiel E, Korfel A, Weller M, Saito K, Mukasa A, Nagae G, Nagane M, Aihara K, Takayanagi S, Tanaka S, Aburatani H, Saito N, Salama S, Sanborn JZ, Grifford M, Brennan C, Mikkelsen T, Jhanwar S, Chin L, Haussler D, Sasayama T, Tanaka K, Nakamizo S, Nishihara M, Tanaka H, Mizukawa K, Kohmura E, Schliesser M, Grimm C, Weiss E, Claus R, Weichenhan D, Weiler M, Hielscher T, Sahm F, Wiestler B, Klein AC, Blaes J, Weller M, Plass C, Wick W, Stragliotto G, Rahbar A, Soderberg-Naucler C, Sulman E, Won M, Ezhilarasan R, Sun P, Blumenthal D, Vogelbaum M, Colman H, Jenkins R, Chakravarti A, Jeraj R, Brown P, Jaeckle K, Schiff D, Dignam J, Atkins J, Brachman D, Werner-Wasik M, Gilbert M, Mehta M, Aldape K, Terashima K, Shen J, Luan J, Yu A, Suzuki T, Nishikawa R, Matsutani M, Liang Y, Man TK, Lau C, Trister A, Tokita M, Mikheeva S, Mikheev A, Friend S, Rostomily R, van den Bent M, Erdem L, Gorlia T, Taphoorn M, Kros J, Wesseling P, Dubbink H, Ibdaih A, Sanson M, French P, van Thuijl H, Mazor T, Johnson B, Fouse S, Heimans J, Wesseling P, Ylstra B, Reijneveld J, Taylor B, Berger M, Chang S, Costello J, Prabowo A, van Thuijl H, Scheinin I, van Essen H, Spliet W, Ferrier C, van Rijen P, Veersema T, Thom M, Meeteren ASV, Reijneveld J, Ylstra B, Wesseling P, Aronica E, Kim H, Zheng S, Mikkelsen T, Brat DJ, Virk S, Amini S, Sougnez C, Chin L, Barnholtz-Sloan J, Verhaak RGW, Watts C, Sottoriva A, Spiteri I, Piccirillo S, Touloumis A, Collins P, Marioni J, Curtis C, Tavare S, Weiss E, Grimm C, Schliesser M, Hielscher T, Claus R, Sahm F, Wiestler B, Klein AC, Blaes J, Tews B, Weiler M, Weichenhan D, Hartmann C, Weller M, Plass C, Wick W, Yeung TPC, Al-Khazraji B, Morrison L, Hoffman L, Jackson D, Lee TY, Yartsev S, Bauman G, Zheng S, Fu J, Vegesna R, Mao Y, Heathcock LE, Torres-Garcia W, Ezhilarasan R, Wang S, McKenna A, Chin L, Brennan CW, Yung WKA, Weinstein JN, Aldape KD, Sulman EP, Chen K, Koul D, Verhaak RGW. OMICS AND PROGNSTIC MARKERS. Neuro Oncol 2013; 15:iii136-iii155. [PMCID: PMC3823898 DOI: 10.1093/neuonc/not183] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/21/2023] Open
|
23
|
Bie L, Ju Y, Jin Z, Donovan L, Birks S, Grunewald L, Zmuda F, Pilkington G, Kaul A, Chen YH, Dahiya S, Emnett R, Gianino S, Gutmann D, Poschl J, Bianchi E, Bockstaller M, Neumann P, Schuller U, Gevorgian A, Morozova E, Kazantsev I, Iukhta T, Safonova S, Punanov Y, Zheludkova O, Afanasyev B, Buss M, Remke M, Gandhi K, Kool M, Northcott P, Pfister S, Taylor M, Castellino R, Thompson J, Margraf L, Donahue D, Head H, Murray J, Burger P, Wortham M, Reitman Z, He Y, Bigner D, Yan H, Lee C, Triscott J, Foster C, Manoranjan B, Pambid MR, Fotovati A, Berns R, Venugopal C, O'Halloran K, Narendran A, Northcott P, Taylor MD, Singh SK, Singhal A, Rassekh R, Maxwell CA, Dunham C, Dunn SE, Pambid MR, Berns R, Hu K, Adomat H, Moniri M, Chin MY, Hessein M, Zisman N, Maurer N, Dunham C, Guns E, Dunn S, Koks C, De Vleeschouwer S, Graf N, Van Gool S, D'Asti E, Huang A, Korshunov A, Pfister S, Rak J, Gump W, Moriarty T, Gump W, Skjei K, Karkare S, Castelo-Branco P, Choufani S, Mack S, Gallagher D, Zhang C, Merino D, Wasserman J, Kool M, Jones DT, Croul S, Kreitzer F, Largaespada D, Conklin B, Taylor M, Weiss W, Garzia L, Morrissy S, Zayne K, Wu X, Dirks P, Hawkins C, Dick J, Stein L, Collier L, Largaespada D, Dupuy A, Taylor M, Rampazzo G, Moraes L, Paniago M, Oliveira I, Hitzler J, Silva N, Cappellano A, Cavalheiro S, Alves MT, Cerutti J, Toledo S, Liu Z, Zhao X, Mao H, Baxter P, Wang JCY, Huang Y, Yu L, Su J, Adekunle A, Perlaky L, Hurwitz M, Hurwitz R, Lau C, Chintagumpala M, Blaney S, Baruchel S, Li XN, Zhang J, Hariono S, Hashizume R, Fan Q, James CD, Weiss WA, Nicolaides T, Madsen PJ, Slaunwhite ES, Dirks PB, Ma JF, Henn RE, Hanno AG, Boucher KL, Storm PB, Resnick AC, Lourdusamy A, Rogers H, Ward J, Rahman R, Malkin D, Gilbertson R, Grundy R, Lourdusamy A, Rogers H, Ward J, Rahman R, Gilbertson R, Grundy R, Karajannis M, Fisher M, Pfister S, Milla S, Cohen K, Legault G, Wisoff J, Harter D, Merkelson A, Bloom M, Dhall G, Jones D, Korshunov A, Taylor MD, Pfister S, Eberhart C, Sievert A, Resnick A, Zagzag D, Allen J, Hankinson T, Gump J, Serrano-Almeida C, Torok M, Weksberg R, Handler M, Liu A, Foreman N, Garancher A, Rocques N, Miquel C, Sainte-Rose C, Delattre O, Bourdeaut F, Eychene A, Tabori U, Pouponnot C, Danielpour M, Levy R, Antonuk CD, Rodriguez J, Aravena JM, Kim GB, Gate D, Bannykh S, Svendsen C, Huang X, Town T, Breunig J, Amakye D, Robinson D, Rose K, Cho YJ, Ligon KL, Sharp T, Ando Y, Geoerger B, He Y, Doz F, Ashley D, Hargrave D, Casanova M, Tawbi H, Heath J, Bouffet E, Brandes AA, Chisholm J, Rodon J, Dubuc AM, Thomas A, Mita A, MacDonald T, Kieran M, Eisenstat D, Song X, Danielpour M, Levy R, Antonuk CD, Rodriguez J, Hashizume R, Aravena JM, Kim GB, Gate D, Bannykh S, Svendsen C, Town T, Breunig J, Morrissy AS, Mayoh C, Lo A, Zhang W, Thiessen N, Tse K, Moore R, Mungall A, Wu X, Van Meter TE, Cho YJ, Collins VP, MacDonald TJ, Li XN, Stehbens S, Fernandez-Lopez A, Malkin D, Marra MA, Taylor MD, Karajannis M, Legault G, Hagiwara M, Vega E, Merkelson A, Wisoff J, Younger S, Golfinos J, Roland JT, Allen J, Antonuk CD, Levy R, Kim GB, Town T, Danielpour M, Breunig J, Pak E, Barshow S, Zhao X, Ponomaryov T, Segal R, Levy R, Antonuk CD, Aravena JM, Kim GB, Svendsen C, Town T, Danielpour M, Zhu S, Breunig J, Chi S, Cohen K, Fisher M, Biegel J, Bowers D, Fangusaro J, Manley P, Janss A, Zimmerman MA, Wu X, Kieran M, Sayour E, Pham C, Sanchez-Perez L, Snyder D, Flores C, Kemeny H, Xie W, Cui X, Bigner D, Taylor MD, Sampson J, Mitchell D, Bandopadhayay P, Nguyen B, Masoud S, Vue N, Gholamin S, Yu F, Schubert S, Bergthold G, Weiss WA, Mitra S, Qi J, Bradner J, Kieran M, Beroukhim R, Cho YJ, Reddick W, Glass J, Ji Q, Paulus E, James CD, Gajjar A, Ogg R, Vanner R, Remke M, Aviv T, Lee L, Zhu X, Clarke I, Taylor M, Dirks P, Shuman MA, Hamilton R, Pollack I, Calligaris D, Liu X, Feldman D, Thompson C, Ide J, Buhrlage S, Gray N, Kieran M, Jan YN, Stiles C, Agar N, Remke M, Cavalli FMG, Northcott PA, Kool M, Pfister SM, Taylor MD, Project MAGIC, Rakopoulos P, Jan LY, Pajovic S, Buczkowicz P, Morrison A, Bouffet E, Bartels U, Becher O, Hawkins C, Truffaux N, Puget S, Philippe C, Gump W, Castel D, Taylor K, Mackay A, Le Dret L, Saulnier P, Calmon R, Boddaert N, Blauwblomme T, Sainte-Rose C, Jones C, Mutchnick I, Grill J, Liu X, Ebling M, Ide J, Wang L, Davis E, Marchionni M, Stuart D, Alberta J, Kieran M, Li KKW, Stiles C, Agar N, Remke M, Cavalli FMG, Northcott PA, Kool M, Pfister SM, Taylor MD, Project MAGIC, Tien AC, Pang JCS, Griveau A, Rowitch D, Ramkissoon L, Horowitz P, Craig J, Ramkissoon S, Rich B, Bergthold G, Tabori U, Taha H, Ng HK, Bowers D, Hawkins C, Packer R, Eberhart C, Goumnerova L, Chan J, Santagata S, Pomeroy S, Ligon A, Kieran M, Jackson S, Beroukhim R, Ligon K, Kuan CT, Chandramohan V, Keir S, Pastan I, Bigner D, Zhou Z, Ho S, Voss H, Patay Z, Souweidane M, Salloum R, DeWire M, Fouladi M, Goldman S, Chow L, Hummel T, Dorris K, Miles L, Sutton M, Howarth R, Stevenson C, Leach J, Griesinger A, Donson A, Hoffman L, Birks D, Amani V, Handler M, Foreman N, Sangar MC, Pai A, Pedro K, Ditzler SH, Girard E, Olson J, Gustafson WC, Meyerowitz J, Nekritz E, Charron E, Matthay K, Hertz N, Onar-Thomas A, Shokat K, Weiss W, Hanaford A, Raabe E, Eberhart C, Griesinger A, Donson A, Hoffman L, Amani V, Birks D, Gajjar A, Handler M, Mulcahy-Levy J, Foreman N, Olow AK, Dasgupta T, Yang X, Mueller S, Hashizume R, Kolkowitz I, Weiss W, Broniscer A, Resnick AC, Sievert AJ, Nicolaides T, Prados MD, Berger MS, Gupta N, James CD, Haas-Kogan DA, Flores C, Pham C, Dietl SM, Snyder D, Sanchez-Perez L, Bigner D, Sampson J, Mitchell D, Prakash V, Batanian J, Guzman M, Geller T, Pham CD, Wolfl M, Pei Y, Flores C, Snyder D, Bigner DD, Sampson JH, Wechsler-Reya RJ, Mitchell DA, Van Ommeren R, Venugopal C, Manoranjan B, Beilhack A, McFarlane N, Hallett R, Hassell J, Dunn S, Singh S, Dasgupta T, Olow A, Yang X, Hashizume R, Mueller S, Riedel S, Nicolaides T, Kolkowitz I, Weiss W, Prados M, Gupta N, James CD, Haas-Kogan D, Zhao H, Li L, Picotte K, Monoranu C, Stewart R, Modzelewska K, Boer E, Picard D, Huang A, Radiloff D, Lee C, Dunn S, Hutt M, Nazarian J, Dietl S, Price A, Lim KJ, Warren K, Chang H, Eberhart CG, Raabe EH, Persson A, Huang M, Chandler-Militello D, Li N, Vince GH, Berger M, James D, Goldman S, Weiss W, Lindquist R, Tate M, Rowitch D, Alvarez-Buylla A, Hoffman L, Donson A, Eyrich M, Birks D, Griesinger A, Amani V, Handler M, Foreman N, Meijer L, Walker D, Grundy R, O'Dowd S, Jaspan T, Schlegel PG, Dineen R, Fotovati A, Radiloff D, Coute N, Triscott J, Chen J, Yip S, Louis D, Toyota B, Hukin J, Weitzel D, Rassekh SR, Singhal A, Dunham C, Dunn S, Ahsan S, Hanaford A, Taylor I, Eberhart C, Raabe E, Sun YG, Ashcraft K, Stiles C, Han L, Zhang K, Chen L, Shi Z, Pu P, Dong L, Kang C, Cordero F, Lewis P, Liu C, Hoeman C, Schroeder K, Allis CD, Becher O, Gururangan S, Grant G, Driscoll T, Archer G, Herndon J, Friedman H, Li W, Kurtzberg J, Bigner D, Sampson J, Mitchell D, Yadavilli S, Kambhampati M, Becher O, MacDonald T, Bellamkonds R, Packer R, Buckley A, Nazarian J, DeWire M, Fouladi M, Stewart C, Wetmore C, Hawkins C, Jacobs C, Yuan Y, Goldman S, Fisher P, Rodriguez R, Rytting M, Bouffet E, Khakoo Y, Hwang E, Foreman N, Gilbert M, Gilbertson R, Gajjar A, Saratsis A, Yadavilli S, Wetzel W, Snyder K, Kambhampati M, Hall J, Raabe E, Warren K, Packer R, Nazarian J, Thompson J, Griesinger A, Foreman N, Spazojevic I, Rush S, Levy JM, Hutt M, Karajannis MA, Shah S, Eberhart CG, Raabe E, Rodriguez FJ, Gump J, Donson A, Tovmasyan A, Birks D, Handler M, Foreman N, Hankinson T, Torchia J, Khuong-Quang DA, Ho KC, Picard D, Letourneau L, Chan T, Peters K, Golbourn B, Morrissy S, Birks D, Faria C, Foreman N, Taylor M, Rutka J, Pfister S, Bouffet E, Hawkins C, Batinic-Haberle I, Majewski J, Kim SK, Jabado N, Huang A, Ladner T, Tomycz L, Watchmaker J, Yang T, Kaufman L, Pearson M, Dewhirst M, Ogg RJ, Scoggins MA, Zou P, Taherbhoy S, Jones MM, Li Y, Glass JO, Merchant TE, Reddick WE, Conklin HM, Gholamin S, Gajjar A, Khan A, Kumar A, Tye GW, Broaddus WC, Van Meter TE, Shih DJH, Northcott PA, Remke M, Korshunov A, Mitra S, Jones DTW, Kool M, Pfister SM, Taylor MD, Mille F, Levesque M, Remke M, Korshunov A, Izzi L, Kool M, Richard C, Northcott PA, Taylor MD, Pfister SM, Charron F, Yu F, Masoud S, Nguyen B, Vue N, Schubert S, Tolliday N, Kong DS, Sengupta S, Weeraratne D, Schreiber S, Cho YJ, Birks D, Jones K, Griesinger A, Amani V, Handler M, Vibhakar R, Achrol A, Foreman N, Brown R, Rangan K, Finlay J, Olch A, Freyer D, Bluml S, Gate D, Danielpour M, Rodriguez J, Shae JJ, Kim GB, Levy R, Bannykh S, Breunig JJ, Town T, Monje-Deisseroth M, Cho YJ, Weissman I, Cheshier S, Buczkowicz P, Rakopoulos P, Bouffet E, Morrison A, Bartels U, Becher O, Hawkins C, Dey A, Kenney A, Van Gool S, Pauwels F, De Vleeschouwer S, Barszczyk M, Buczkowicz P, Castelo-Branco P, Mack S, Nethery-Brokx K, Morrison A, Taylor M, Dirks P, Tabori U, Hawkins C, Chandramohan V, Keir ST, Bao X, Pastan IH, Kuan CT, Bigner DD, Bender S, Jones D, Kool M, Sturm D, Korshunov A, Lichter P, Pfister SM, Chen M, Lu J, Wang J, Keir S, Zhang M, Zhao S, Mook R, Barak L, Lyerly HK, Chen W, Ramachandran C, Nair S, Escalon E, Khatib Z, Quirrin KW, Melnick S, Kievit F, Stephen Z, Wang K, Silber J, Ellenbogen R, Zhang M, Hutzen B, Studebaker A, Bratasz A, Powell K, Raffel C, Guo C, Chang CC, Wortham M, Chen L, Kernagis D, Qin X, Cho YW, Chi JT, Grant G, McLendon R, Yan H, Ge K, Papadopoulos N, Bigner D, He Y, Cristiano B, Venkataraman S, Birks DK, Alimova I, Harris PS, Dubuc A, Taylor MD, Foreman NK, Vibhakar R, Ichimura K, Fukushima S, Totoki Y, Suzuki T, Mukasa A, Saito N, Kumabe T, Tominaga T, Kobayashi K, Nagane M, Iuchi T, Mizoguchi M, Sasaki T, Tamura K, Sugiyama K, Narita Y, Shibui S, Matsutani M, Shibata T, Nishikawa R, Northcott P, Zichner T, Jones D, Kool M, Jager N, Feychting M, Lannering B, Tynes T, Wesenberg F, Hauser P, Ra YS, Zitterbart K, Jabado N, Chan J, Fults D, Mueller S, Grajkowska W, Lichter P, Korbel J, Pfister S, Kool M, Jones DTW, Jaeger N, Northcott PA, Pugh T, Hovestadt V, Markant SL, Esparza LA, Bourdeaut F, Remke M, Taylor MD, Cho YJ, Pomeroy SL, Schueller U, Korshunov A, Eils R, Wechsler-Reya RJ, Lichter P, Pfister SM, Keir S, Pegram C, Lipp E, Rasheed A, Chandramohan V, Kuan CT, Kwatra M, Yan H, Bigner D, Chornenkyy Y, Buczkowicz P, Agnihotri S, Becher O, Hawkins C, Rogers H, Mayne C, Kilday JP, Coyle B, Grundy R, Sun T, Warrington N, Luo J, Brooks M, Dahiya S, Sengupta R, Rubin J, Erdreich-Epstein A, Robison N, Ren X, Zhou H, Ji L, Margo A, Jones D, Pfister S, Kool M, Sposto R, Asgharzadeh S, Clifford S, Gustafsson G, Ellison D, Figarella-Branger D, Doz F, Rutkowski S, Lannering B, Pietsch T, Broniscer A, Tatevossian R, Sabin N, Klimo P, Dalton J, Lee R, Gajjar A, Ellison D, Garzia L, Dubuc A, Pitcher G, Northcott P, Mariampillai A, Chan T, Skowron P, Wu X, Yao Y, Hawkins C, Peacock J, Zayne K, Croul S, Rutka J, Kenney A, Huang A, Yang V, Baylin S, Salter M, Taylor M, Ward S, Sengupta R, Rubin J, Garzia L, Morrissy S, Skowron P, Jelveh S, Lindsay P, Largaespada D, Collier L, Dupuy A, Hill R, Taylor M, Lulla RR, Laskowski J, Fangusaro J, DiPatri AJ, Alden T, Vanin EF, Tomita T, Goldman S, Soares MB, Rajagopal MU, Lau LS, Hathout Y, Gordish-Dressman H, Rood B, Datar V, Bochare S, Singh A, Khatau S, Fangusaro J, Goldman S, Lulla R, Rajaram V, Gopalakrishnan V, Morfouace M, Shelat A, Jaccus M, Freeman B, Zindy F, Robinson G, Guy K, Stewart C, Gajjar A, Roussel M, Krebs S, Chow K, Yi Z, Brawley V, Ahmed N, Gottschalk S, Lerner R, Harness J, Yoshida Y, Santos R, Torre JDL, Nicolaides T, Ozawa T, James D, Petritsch C, Vitte J, Chareyre F, Stemmer-Rachamimov A, Giovannini M, Hashizume R, Yu-Jen L, Tom M, Ihara Y, Huang X, Waldman T, Mueller S, Gupta N, James D, Shevtsov M, Yakovleva L, Nikolaev B, Dobrodumov A, Onokhin K, Bychkova N, Mikhrina A, Khachatryan W, Guzhova I, Martynova M, Bystrova O, Ischenko A, Margulis B, Martin A, Nirschl C, Polanczyk M, Cohen K, Pardoll D, Drake C, Lim M, Crowther A, Chang S, Yuan H, Deshmukh M, Gershon T, Meyerowitz JG, Gustafson WC, Nekritz EA, Swartling F, Shokat KM, Ruggero D, Weiss WA, Bergthold G, Rich B, Bandopadhayay P, Chan J, Santaga S, Hoshida Y, Golub T, Tabak B, Ferrer-Luna R, Grill J, Wen PY, Stiles C, Kieran M, Ligon K, Beroukhim R, Lulla RR, Laskowski J, Gireud M, Fangusaro J, Goldman S, Gopalakrishnan V, Merino D, Shlien A, Pienkowska M, Tabori U, Gilbertson R, Malkin D, Mueller S, Hashizume R, Yang X, Kolkowitz I, Olow A, Phillips J, Smirnov I, Tom M, Prados M, Berger M, Gupta N, Haas-Kogan D, Beez T, Sarikaya-Seiwert S, Janssen G, Felsberg J, Steiger HJ, Hanggi D, Marino AM, Baryawno N, Johnsen JI, Ostman A, Wade A, Engler JR, Robinson AE, Phillips JJ, Witt H, Sill M, Mack SC, Wani KM, Lambert S, Tzaridis T, Bender S, Jones DT, Milde T, Northcott PA, Kool M, von Deimling A, Kulozik AE, Witt O, Lichter P, Collins VP, Aldape K, Taylor MD, Korshunov A, Pfister SM, Hatcher R, Das C, Datar V, Taylor P, Singh A, Lee D, Fuller G, Ji L, Fangusaro J, Rajaram V, Goldman S, Eberhart C, Gopalakrishnan V, Griveau A, Lerner R, Ihrie R, Sugiarto S, Ihara Y, Reichholf B, Huillard E, Mcmahon M, James D, Phillips J, Buylla AA, Rowitch D, Petritsch C, Snuderl M, Batista A, Kirkpatrick N, de Almodovar CR, Riedemann L, Knevels E, Schmidt T, Peterson T, Roberge S, Bais C, Yip S, Hasselblatt M, Rossig C, Ferrara N, Klagsbrun M, Duda D, Fukumura D, Xu L, Carmeliet P, Jain R, Nguyen A, Pencreach E, Lasthaus C, Lobstein V, Guerin E, Guenot D, Entz-Werle N, Diaz R, Golbourn B, Faria C, Shih D, MacKenzie D, Picard D, Bryant M, Smith C, Taylor M, Huang A, Rutka J, Gromeier M, Desjardins A, Sampson JH, Threatt SJE, Herndon JE, Friedman A, Friedman HS, Bigner DD, Cavalli FMG, Morrissy AS, Li Y, Chu A, Remke M, Thiessen N, Mungall AJ, Bader GD, Malkin D, Marra MA, Taylor MD, Manoranjan B, Wang X, Hallett R, Venugopal C, Mack S, McFarlane N, Nolte S, Scheinemann K, Gunnarsson T, Hassell J, Taylor M, Lee C, Triscott J, Foster C, Dunham C, Hawkins C, Dunn S, Singh S, McCrea HJ, Bander E, Venn RA, Reiner AS, Iorgulescu JB, Puchi LA, Schaefer PM, Cederquist G, Greenfield JP, Tsoli M, Luk P, Dilda P, Hogg P, Haber M, Ziegler D, Mack S, Agnihotri S, Witt H, Shih D, Wang X, Ramaswamy V, Zayne K, Bertrand K, Massimi L, Grajkowska W, Lach B, Gupta N, Weiss W, Guha A, Zadeh G, Rutka J, Korshunov A, Pfister S, Taylor M, Mack S, Witt H, Jager N, Zuyderduyn S, Nethery-Brokx K, Garzia L, Zayne K, Wang X, Barszczyk M, Wani K, Bouffet E, Weiss W, Hawkins C, Rutka J, Bader G, Aldape K, Dirks P, Pfister S, Korshunov A, Taylor M, Engler J, Robinson A, Wade A, Molinaro A, Phillips J, Ramaswamy V, Remke M, Bouffet E, Faria C, Shih D, Gururangan S, McLendon R, Schuller U, Ligon K, Pomeroy S, Jabado N, Dunn S, Fouladi M, Rutka J, Hawkins C, Tabori U, Packer R, Pfister S, Korshunov A, Taylor M, Faria C, Dubuc A, Golbourn B, Diaz R, Agnihotri S, Sabha N, Luck A, Leadly M, Reynaud D, Wu X, Remke M, Ramaswamy V, Northcott P, Pfister S, Croul S, Kool M, Korshunov A, Smith C, Taylor M, Rutka J, Pietsch T, Doerner E, Muehlen AZ, Velez-Char N, Warmuth-Metz M, Kortmann R, von Hoff K, Friedrich C, Rutkowski S, von Bueren A, Lu YJ, James CD, Hashizume R, Mueller S, Phillips J, Gupta N, Sturm D, Northcott PA, Jones DTW, Korshunov A, Picard D, Lichter P, Huang A, Pfister SM, Kool M, Ward J, Teague C, Shriyan B, Grundy R, Rahman R, Taylor K, Mackay A, Morozova O, Butterfield Y, Truffaux N, Philippe C, Vinci M, de Torres C, Cruz O, Mora J, Hargrave D, Puget S, Yip S, Jones C, Grill J, Smith S, Ward J, Tan C, Grundy R, Rahman R, Bjerke L, Mackay A, Nandhabalan M, Burford A, Jury A, Popov S, Bax D, Carvalho D, Taylor K, Vinci M, Bajrami I, McGonnell I, Lord C, Reis R, Hargrave D, Ashworth A, Workman P, Jones C, Carvalho D, Mackay A, Burford A, Bjerke L, Chen L, Kozarewa I, Lord C, Ashworth A, Hargrave D, Reis R, Jones C, Marigil M, Jauregui PJ, Alonso M, Chan TS, Hawkins C, Picard D, Henkin J, Huang A, Trubicka J, Kucharczyk M, Pelc M, Chrzanowska K, Ciara E, Perek-Polnik M, Grajkowska W, Piekutowska-Abramczuk D, Jurkiewicz D, Luczak S, Borucka-Mankiewicz M, Kowalski P, Krajewska-Walasek M, de Mola RML, Laskowski J, Fangusaro J, Costa FF, Vanin EF, Goldman S, Soares MB, Lulla RR, Mann A, Venugopal C, Vora P, Singh M, van Ommeren R, McFarlane N, Manoranjan B, Qazi M, Scheinemann K, MacDonald P, Delaney K, Whitton A, Dunn S, Singh S, Sievert A, Lang SS, Boucher K, Madsen P, Slaunwhite E, Choudhari N, Kellet M, Storm P, Resnick A, Agnihotri S, Burrell K, Fernandez N, Golbourn B, Clarke I, Barszczyk M, Sabha N, Dirks P, Jones C, Rutka J, Zadeh G, Hawkins C, Murphy B, Obad S, Bihannic L, Ayrault O, Zindy F, Kauppinen S, Roussel M, Golbourn B, Agnihotri S, Cairns R, Mischel P, Aldape K, Hawkins C, Zadeh G, Rutka J, Rush S, Donson A, Kleinschmidt-DeMasters B, Bemis L, Birks D, Chan M, Smith A, Handler M, Foreman N, Gronych J, Jones DTW, Zuckermann M, Hutter S, Korshunov A, Kool M, Ryzhova M, Reifenberger G, Pfister SM, Lichter P, Jones DTW, Hovestadt V, Picelli S, Wang W, Northcott PA, Kool M, Jager N, Reifenberger G, Rutkowski S, Pietsch T, Sultan M, Yaspo ML, Landgraf P, Eils R, Korshunov A, Zapatka M, Pfister SM, Radlwimmer B, Lichter P, Huang Y, Mao H, Wang Y, Kogiso M, Zhao X, Baxter P, Man C, Wang Z, Zhou Y, Li XN, Chung AH, Crabtree D, Schroeder K, Becher OJ, Panosyan E, Wang Y, Lasky J, Liu Z, Zhao X, Wang Y, Mao H, Huang Y, Kogiso M, Baxter P, Adesina A, Su J, Picard D, Huang A, Perlaky L, Chintagumpala M, Lau C, Blaney S, Li XN, Huang M, Persson A, Swartling F, Moriarity B. Abstracts. Neuro Oncol 2013. [DOI: 10.1093/neuonc/not047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
24
|
St Lawrence K, Verdecchia K, Elliott J, Tichauer K, Diop M, Hoffman L, Lee TY. Kinetic model optimization for characterizing tumour physiology by dynamic contrast-enhanced near-infrared spectroscopy. Phys Med Biol 2013; 58:1591-604. [PMID: 23417099 DOI: 10.1088/0031-9155/58/5/1591] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Dynamic contrast-enhanced (DCE) methods are widely used with magnetic resonance imaging and computed tomography to assess the vascular characteristics of tumours since these properties can affect the response to radiotherapy and chemotherapy. In contrast, there have been far fewer studies using optical-based applications despite the advantages of low cost and safety. This study investigated an appropriate kinetic model for optical applications to characterize tumour haemodynamics (blood flow, F, blood volume, V(b), and vascular heterogeneity) and vascular leakage (permeability surface-area product, PS). DCE data were acquired with two dyes, indocyanine green (ICG) and 800 CW carboxylate (IRD(cbx)), from a human colon tumour xenograph model in rats. Due to the smaller molecular weight of IRD(cbx) (1166 Da) compared to albumin-bound ICG (67 kDa), PS of IRD(cbx) was significantly larger; however, no significant differences in F and V(b) were found between the dyes as expected. Error analysis demonstrated that all parameters could be estimated with an uncertainty less than 5% due to the high temporal resolution and signal-to-noise ratio of the optical measurements. The next step is to adapt this approach to optical imaging to generate haemodynamics and permeability maps, which should enhance the clinical interest in optics for treatment monitoring.
Collapse
Affiliation(s)
- K St Lawrence
- Imaging Division, Lawson Health Research Institute, 268 Grosvenor Street, London, Ontario, N6A 4V2, Canada.
| | | | | | | | | | | | | |
Collapse
|
25
|
Floyd SR, Pacold ME, Clarke SM, Blake E, Fydrych A, Ho R, Lee MJ, Root DE, Carpenter AE, Sabatini DM, French CA, Bradner JE, Chen CC, Yaffe MB, Le Rhun E, Massin F, Lefevre A, Bonneterre J, Bittencourt MDC, Faure G, Hiramatsu R, Kawabata S, Yamada Y, Miyatake SI, Kuroiwa T, Li S, Chou AP, Chen W, Chen R, Deng Y, Phillips HS, Faull KF, Cloughesy T, Liau LM, Lai A, Mori K, Ishikura R, Tomogane Y, Izumoto S, Arita N, Piao J, Auyeung G, Policarpio E, Tabar V, Yeung TPC, Morrison L, Hoffman L, Lee TY, Bauman G, Yartsev S, Ryu S, Kolozsvary A, Lapanowski M, Jenrow K, Brown S, Kim JH, Brown RJ, Love J, Warburton D, McBride W, Bluml S, Ren X, Vanderwaal B, Jaboin J, Baldock AL, Anh S, Rockne R, Neal M, Clark-Swanson K, Sterin G, Trister AD, Malone H, Ebiana V, Sonabend AM, Mrugala M, Rockhill JK, Silbergeld DL, Lai A, Cloughesy T, McKhann GM, Bruce JN, Rostomily R, Canoll P, Swanson KR, Hawkins-Daarud A, Baldock A, Bridge C, Corwin D, Rockhill JK, Mrugala MM, Rockne R, Swanson KR, Baldock AL, Yagle K, Anh S, Born D, Swanson P, Rockne R, Swanson KR, Hawkins-Daarud A, Rockne R, Swanson KR. LAB-RADIOBIOLOGY. Neuro Oncol 2012. [DOI: 10.1093/neuonc/nos237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
26
|
Gilpin D, Hoffman L, McGrath S, McCaughan J, Reid A, Burns J, Tunney M, Elborn J. WS18.5 MRSA in cystic fibrosis: potential for transmission within CF centres? J Cyst Fibros 2012. [DOI: 10.1016/s1569-1993(12)60133-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
27
|
Cuthbertson L, Rogers G, Hoffman L, Oliver A, Wing P, Carroll M, Bruce K, Walker A, van der Gast C. 136 Impact of propidium monoazide treatment on CF bacterial community pyrosequencing analysis. J Cyst Fibros 2012. [DOI: 10.1016/s1569-1993(12)60306-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
28
|
Howell D, Mayo S, Currie S, Jones G, Boyle M, Hack T, Green E, Hoffman L, Collacutt V, McLeod D, Simpson J. Psychosocial health care needs assessment of adult cancer patients: a consensus-based guideline. Support Care Cancer 2012; 20:3343-54. [PMID: 22581015 DOI: 10.1007/s00520-012-1468-x] [Citation(s) in RCA: 54] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2011] [Accepted: 04/09/2012] [Indexed: 11/25/2022]
Abstract
PURPOSE Although recommended as an essential part of cancer care, there is limited evidence regarding the optimum approach to psychosocial health care needs assessment in this setting. To address this gap, the Cancer Journey Action Group of the Canadian Partnership Against Cancer (CPAC) and the Canadian Association of Psychosocial Oncology (CAPO) partnered to develop consensus-based recommendations regarding the routine assessment of psychosocial and supportive care needs. The purpose of this paper is to summarize the evidence that informed the guideline and disseminate the recommendations developed by the expert panel. METHODS Clinical practice recommendations were developed by a panel comprised of psychosocial and interdisciplinary experts. Recommendations were informed by a review of oncology clinical practice guidelines, systematic reviews, and primary research, through to May 2008. Following expert consensus on the recommendations, the clinical practice guideline was externally reviewed by a purposively selected sample of national and international interdisciplinary experts. RESULTS A total of nine clinical practice guidelines, three systematic reviews, and 14 primary studies were included in the review. Overall, this body of literature suggested that routine collection of psychosocial health care data has an influence on communication with oncologists and other study specific outcomes, but the evidence was limited by heterogeneity and methodological limitations. Based on the interpretation of this body of evidence by clinical experts, research methodologists, and external reviewers, 12 substantive recommendations were developed regarding the process and parameters of psychosocial needs assessment in adult cancer patients. CONCLUSION Given the limitations in the current body of evidence, there remains a need for rigorous empirical research regarding the optimal approach to psychosocial needs assessment, including the specific characteristics that influence effectiveness on patient outcomes. This guideline fills an important gap in psychosocial care, regarding the routine assessment of psychosocial health care needs.
Collapse
Affiliation(s)
- D Howell
- University Health Network (Princess Margaret Hospital), Toronto, ON, Canada.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
Adamina M, Champagne BJ, Hoffman L, Ermlich MB, Delaney CP. Randomized clinical trial comparing the cost and effectiveness of bipolar vessel sealers versus clips and vascular staplers for laparoscopic colorectal resection. Br J Surg 2011; 98:1703-12. [PMID: 21997317 DOI: 10.1002/bjs.7679] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/07/2011] [Indexed: 12/22/2022]
Abstract
BACKGROUND The widespread use of laparoscopy has resulted in a variety of instruments being used routinely for vascular control. This randomized controlled trial evaluated the cost-effectiveness of bipolar vessel sealer (BVS) compared with clips and vascular stapler (CVS) in straight laparoscopic colorectal resection. METHODS Patients scheduled for elective colorectal resection, including benign and malignant diseases, were randomized to either BVS or CVS for vascular control. Patients whose operation was converted to an open approach before pedicle ligation were excluded. The primary endpoints were duration of operation, including time taken to control vascular pedicles, and cost of disposable instruments for vascular control. RESULTS Of 114 patients randomized to BVS (60 patients) or CVS (54), 14 did not receive the allocated vascular control device, leaving 55 and 45 respectively for analysis. The BVS reduced the time spent for vascular control by a mean of 6·9 min (P = 0·031) and reduced the cost of disposable instruments for vascular control by US $ 80·7 per patient (P = 0·043). For total colectomy, the BVS reduced the operating time by 103·6 min (P = 0·023) and the time taken for vascular control by 16·8 min (P = 0·022). For left colectomy, it decreased the time to vascular control by 9·3 min (P = 0·021). In multivariable analysis, the cost of disposable instruments for vascular control was independently reduced by randomization to BVS, type of procedure, female sex and estimated blood loss. The mean cost reduction was $ 88·2 for left colectomy (P = 0·037), $ 377·7 (P = 0·005) for total colectomy and $ 366·9 (P = 0·012) for proctectomy. Conversely, use of the BVS increased the cost of instruments used for vascular control in right colectomy by $ 92·6 (P = 0·012). CONCLUSION BVS devices are expedient and cost-efficient in proctectomy, left and total colectomy procedures.
Collapse
Affiliation(s)
- M Adamina
- Division of Colorectal Surgery, University Hospitals Case Medical Center, 11100 Euclid Avenue, Cleveland, Ohio 44106-5047, USA
| | | | | | | | | |
Collapse
|
30
|
Pieterse E, Swarts I, Hoffman L. The effect of porcine somatotropin (pST) and gender on production parameters and tissue yield of pigs slaughtered at 135 kg live weight. S AFR J ANIM SCI 2010. [DOI: 10.4314/sajas.v39i4.51132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
31
|
Lindenmayer J, Kaushik S, Branch C, McGurk S, Khan A, Li H, Hoffman L. Does computerized cognitive remediation change brain activation patterns in schizophrenia: fMRI pilot data. Eur Psychiatry 2008. [DOI: 10.1016/j.eurpsy.2008.01.827] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
32
|
Aravindan N, Cata JP, Hoffman L, Dougherty PM, Riedel BJ, Price KJ, Shaw AD. Effects of isoflurane, pentobarbital, and urethane on apoptosis and apoptotic signal transduction in rat kidney. Acta Anaesthesiol Scand 2006; 50:1229-37. [PMID: 16978161 DOI: 10.1111/j.1399-6576.2006.01102.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
BACKGROUND Renal cell apoptosis contributes significantly to the pathogenesis of acute renal failure. Anesthetic agents have been shown to modulate apoptotic signal transduction in various tissues. We examined the effects of 6 h of different general anesthetic techniques on renal cell apoptosis in rat kidneys. METHODS Twenty-one male Sprague-Dawley rats were randomly allocated into four groups: (i) control, non-anesthetized rats (n= 3) and rats anesthetized with (ii) inhaled isoflurane (n= 6), (iii) intraperitoneal pentobarbital (n= 6), and (iv) intraperitoneal urethane (n= 6). Animals were sacrificed 6 h after the induction of anesthesia. RESULTS Apoptosis was assessed by terminal deoxynucleotidyl transferase-fluorescein end-labeling analysis. RNA was extracted from the left kidney to probe cDNA microarrays. Gene expression was measured as a percentage of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and subsequently confirmed using reverse transcriptase-polymerase chain reaction (RT-PCR). Compared with the control (no anesthesia), urethane significantly (P < 0.001) induced apoptosis in both the renal cortex and medulla. Isoflurane significantly (P < 0.001) inhibited apoptosis in the medulla. Microarray analysis revealed that urethane up-regulated more (74) genes than pentobarbital (16) and isoflurane (10). Isoflurane down-regulated more genes (85) than pentobarbital (74) and urethane (12). These anesthetic-induced modulations were significant (P < 0.05) for 60 isoflurane-, 30 pentobarbital- and 4 urethane-modulated genes. CONCLUSION Our results suggest that general anesthetic drugs have an effect on renal cell apoptosis and apoptotic signal transduction, and thus may potentially affect the risk of subsequent acute renal failure.
Collapse
Affiliation(s)
- N Aravindan
- Division of Anesthesiology and Critical Care, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
| | | | | | | | | | | | | |
Collapse
|
33
|
Avaron F, Hoffman L, Guay D, Akimenko MA. Characterization of two new zebrafish members of the hedgehog family: atypical expression of a zebrafish indian hedgehog gene in skeletal elements of both endochondral and dermal origins. Dev Dyn 2006; 235:478-89. [PMID: 16292774 DOI: 10.1002/dvdy.20619] [Citation(s) in RCA: 90] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
We have characterized two new members of the Hedgehog (Hh) family in zebrafish, ihha and dhh, encoding for orthologues of the tetrapod Indian Hedgehog (Ihh) and Desert Hedgehog (Dhh) genes, respectively. Comparison of ihha and Type X collagen (col10a1) expression during skeletal development show that ihha transcripts are located in hypertrophic chondrocytes of cartilaginous elements of the craniofacial and fin endoskeleton. Surprisingly, col10a1 expression was also detected in cells forming intramembranous bones of the head and in flat cells surrounding cartilaginous structures. The expression of col10a1 in both endochondral and intramembranous bones reflects an atypical composition of the extracellular matrix of the zebrafish craniofacial skeleton. In addition, during fin ray regeneration, both ihha and col10a1 are detected in scleroblasts, osteoblast-like cells secreting the matrix of the dermal bone fin ray. The presence of cartilage markers suggests that the dermal fin ray possesses an intermediate phenotype between cartilage and bone.
Collapse
Affiliation(s)
- F Avaron
- Ottawa Health Research Institute, Ottawa, Ontario, Canada
| | | | | | | |
Collapse
|
34
|
Abstract
BACKGROUND Increasing emphasis on family-centred approaches to services and supports for families of children with disabilities has surfaced the issue of accountability for family outcomes. We present a review of literature about the impacts of children with disabilities on families as a backdrop to proposing family quality of life as a concept that encompasses impacts of disability and one that can be used to assess the impact of supports and services on families. METHOD We briefly introduce the Beach Center Family Quality of Life Scale, providing information about its factor structure, reliability and convergent validity. RESULTS The Beach Center Family Quality of Life Scale contains 25 items assessing family ratings of importance and satisfaction with five domains: Family interaction, Parenting, Emotional well-being, Physical/material well-being and Disability-related supports. CONCLUSION We present a framework for utilizing a measure of family quality of life as a long-term outcome in concert with other short-term measures of service outcomes for families.
Collapse
Affiliation(s)
- J A Summers
- University of Kansas, Lawrence, KS 66045, USA.
| | | | | | | | | | | | | |
Collapse
|
35
|
Nys S, Bruinsma N, Filius PMG, van den Bogaard AE, Hoffman L, Terporten PHW, Wildeboer-Veloo ACM, Degener J, Endtz HP, Stobberingh EE. Effect of Hospitalization on the Antibiotic Resistance of FecalEnterococcus faecalisof Surgical Patients Over Time. Microb Drug Resist 2005; 11:154-8. [PMID: 15910230 DOI: 10.1089/mdr.2005.11.154] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
The prevalence of antibiotic resistant Enterococcus faecalis was determined in fecal samples of 263 patients admitted to the surgical wards of three university-affiliated hospitals on admission, at discharge, and at 1 and 6 months after discharge. A slight increase in the prevalence of antibiotic resistance of E. faecalis was found at discharge for the antibiotics tested compared to those on admission, vancomycin excepted. At 6 months after discharge, the prevalence of resistance for amoxicillin (0%), ciprofloxacin (3%), erythromycin (47%), and oxytetracycline (60%) decreased to the level on admission (respectively 0%, 8%, 45%, and 64%). Gentamicin resistance was the same at discharge (10%) as 1 month later (12%), but decreased 6 months after discharge (8%) to the level on admission (7%). In conclusion, hospitalization resulted in the study population in a slight increase in the prevalence of resistant fecal E. faecalis isolates at discharge, which decreased again (slowly) to the level on admission 6 months after discharge. Thus, the influence of hospitalization on the prevalence of antibiotic resistance in the extramural situation disappears between 1 and 6 months after discharge in this population.
Collapse
Affiliation(s)
- S Nys
- Department of Medical Microbiology, University Hospital Maastricht, Maastricht, The Netherlands
| | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Hoffman L, Chan K, Smith B, Okolo S. The value of saline salpingosonography as a surrogate test of tubal patency in low-resource settings. Int J Fertil Womens Med 2005; 50:135-9. [PMID: 16279507] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Abstract
BACKGROUND Tubal factor, which accounts for 15-30% of infertility in all women, is common in developing countries with high rates of pelvic inflammatory disease but limited resources. It is possible to outline the fallopian tubes by injecting isotonic saline transcervically during transvaginal ultrasound scanning of the pelvis, and both color flow Doppler and 3-dimensional scanning modes have been employed to improve visualization of the tubes, with varying success. METHOD We investigated the value of saline salpingosonography (SSG), using 2-dimensional transvaginal ultrasound scanning, as a screening test of tubal patency in 113 women by comparing SSG findings to those at HSG or laparoscopy. RESULTS The findings at SSG correlated well with the results of HSG or laparoscopy, with an overall concordance of 82.5%. SSG was more accurate at diagnosing patent tubes than blocked tubes and was well tolerated. The results are, however, unreliable when it is difficult to inject the saline and when the patient experiences severe pain during the procedure. CONCLUSION SSG is a useful screening tool for investigating infertility, particularly in low-resource settings.
Collapse
Affiliation(s)
- L Hoffman
- Department of Obstetrics and Gynaecology, North Middlesex University Hospital, London, United Kingdom
| | | | | | | |
Collapse
|
37
|
Park J, Hoffman L, Marquis J, Turnbull AP, Poston D, Mannan H, Wang M, Nelson LL. Toward assessing family outcomes of service delivery: validation of a family quality of life survey. J Intellect Disabil Res 2003; 47:367-384. [PMID: 12787167 DOI: 10.1046/j.1365-2788.2003.00497.x] [Citation(s) in RCA: 115] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
BACKGROUND The concept of family quality of life (QoL) has emerged as an important outcome of service delivery for individuals with disabilities and their families. The present study describes the process of developing a tool to measure family QoL. METHODS AND RESULTS A total of 1197 respondents participated in a national field test. Through factor analysis, the survey was refined in several ways: (1) the preliminary 10-domain structure was reduced to a five-domain structure; (2) a total of 41 items were selected for the revised survey; and (3) wordings were clarified. CONCLUSIONS The implications for future research and practice are discussed.
Collapse
Affiliation(s)
- J Park
- Department of Special Education, Ewha University, Seoul, Korea.
| | | | | | | | | | | | | | | |
Collapse
|
38
|
Miner MH, Robinson BE, Hoffman L, Albright CL, Bockting WO. Improving safer sex measures through the inclusion of relationship and partner characteristics. AIDS Care 2002; 14:827-37. [PMID: 12511215 DOI: 10.1080/0954012021000031895] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
This article describes the development of a safer sex algorithm, which considers the characteristics of a woman's relationship and the HIV risk profile of herself and her primary partner. A sample of 306 low-income, predominantly African American women was recruited to participate in a study of the effectiveness of a sexual health seminar. These women were interviewed three times, at one month prior to seminar administration, three months after the seminar and again nine months after the seminar. Data from these women indicate that using an algorithm that considers the probability of HIV transmission between partners decreases the measured prevalence of unsafe sex in this population by about 17% and lowers the estimate of the average number of unsafe incidents by about four incidents in three months. The algorithm results in measures with adequate levels of temporal stability, which are similar to the more commonly used measure, vaginal or anal intercourse without a condom.
Collapse
Affiliation(s)
- M H Miner
- University of Minnesota, Minnessota 55454, USA.
| | | | | | | | | |
Collapse
|
39
|
|
40
|
Holland B, Portyanko A, Hoffman L, Lee M. Genomic regions controlling vernalization and photoperiod responses in oat. Theor Appl Genet 2002; 105:113-126. [PMID: 12582569 DOI: 10.1007/s00122-001-0845-5] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/07/2001] [Accepted: 10/30/2001] [Indexed: 05/22/2023]
Abstract
Oat genotypes vary for photoperiod and vernalization responses. Vernalization often promotes earlier flowering in fall-sown but not spring-sown cultivars. Longer photoperiods also promote earlier flowering, and the response to longer photoperiods tends to be greater in cultivars from higher latitudes. To investigate the genetic basis of photoperiod and vernalization responses in oat, we mapped QTLs for flowering time under four combinations of photoperiod and vernalization treatments in the Ogle x TAM O-301 mapping population in growth chambers. We also mapped QTLs for flowering time in early spring and late-spring field plantings to determine the genetic basis of response to early spring planting in oat. Three major flowering-time QTLs (on linkage groups OT8, OT31 and OT32) were detected in most conditions. QTLs with smaller effects on flowering were less-consistently observed among treatments. Both vernalization-sensitive and insensitive QTLs were discovered. Longer photoperiod or vernalization alone tended to decrease the effects of flowering-time QTLs. Applied together, longer photoperiod and vernalization interacted synergistically, often on the same genomic regions. Earlier spring planting conferred an attenuated vernalization treatment on seeds. The major flowering-time QTLs mapped in this study matched those mapped previously in the Kanota x Ogle oat mapping population. Between these two studies, we found a concordance of flowering-time QTLs, segregation distortion, and complex genetic linkages. These effects may all be related to chromosomal rearrangements in hexaploid oat. Comparative mapping between oat and other grasses will facilitate molecular analysis of vernalization response in oat.
Collapse
Affiliation(s)
- B. Holland
- USDA-ARS Plant Science Research Unit, Department of Crop Science, Box 7620, North Carolina State University, Raleigh, NC, USA 27695-7620,
| | | | | | | |
Collapse
|
41
|
|
42
|
Tsutsui M, Velapoldi RA, Hoffman L, Suzuki K, Ferrari A. Unusual metalloporphyrins. III. Induced oxidation of cobalt(II) and iron(II) porphyrins by unsaturated hydrocarbons. J Am Chem Soc 2002. [DOI: 10.1021/ja01040a040] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
43
|
Hoffman L. The external credentialing process as a joint endeavor: lessons from the past. Journal of the American Academy of Psychoanalysis 2002; 29:355-63. [PMID: 11685997 DOI: 10.1521/jaap.29.2.355.17258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Affiliation(s)
- L Hoffman
- New York Psychoanalytic Institute, USA
| |
Collapse
|
44
|
Hoffman L. Introducing critical care nursing at an undergraduate level. Can Nurse 2001; 97:26-8. [PMID: 11868226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/23/2023]
Affiliation(s)
- L Hoffman
- Lake-head University School of Nursing, Thunder Bay, Ontario
| |
Collapse
|
45
|
McKay JD, Lesueur F, Jonard L, Pastore A, Williamson J, Hoffman L, Burgess J, Duffield A, Papotti M, Stark M, Sobol H, Maes B, Murat A, Kääriäinen H, Bertholon-Grégoire M, Zini M, Rossing MA, Toubert ME, Bonichon F, Cavarec M, Bernard AM, Boneu A, Leprat F, Haas O, Lasset C, Schlumberger M, Canzian F, Goldgar DE, Romeo G. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 2001; 69:440-6. [PMID: 11438887 PMCID: PMC1235316 DOI: 10.1086/321979] [Citation(s) in RCA: 149] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2001] [Accepted: 06/12/2001] [Indexed: 11/03/2022] Open
Abstract
The familial form of nonmedullary thyroid carcinoma (NMTC) is a complex genetic disorder characterized by multifocal neoplasia and a higher degree of aggressiveness than its sporadic counterpart. In a large Tasmanian pedigree (Tas1) with recurrence of papillary thyroid carcinoma (PTC), the most common form of NMTC, an extensive genomewide scan revealed a common haplotype on chromosome 2q21 in seven of the eight patients with PTC. To verify the significance of the 2q21 locus, we performed linkage analysis in an independent sample set of 80 pedigrees, yielding a multipoint heterogeneity LOD score (HLOD) of 3.07 (alpha=0.42), nonparametric linkage (NPL) 3.19, (P=.001) at marker D2S2271. Stratification based on the presence of at least one case of the follicular variant of PTC, the phenotype observed in the Tas1 family, identified 17 such pedigrees, yielding a maximal HLOD score of 4.17 (alpha=0.80) and NPL=4.99 (P=.00002) at markers AFMa272zg9 and D2S2271, respectively. These results indicate the existence of a susceptibility locus for familial NMTC on chromosome 2q21.
Collapse
Affiliation(s)
- James D. McKay
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Fabienne Lesueur
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Laurence Jonard
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Alessandro Pastore
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Jan Williamson
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Linda Hoffman
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - John Burgess
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Anne Duffield
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Mauro Papotti
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Markus Stark
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Hagay Sobol
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Béatrice Maes
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Arnaud Murat
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Helena Kääriäinen
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Mireille Bertholon-Grégoire
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Michele Zini
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Mary Anne Rossing
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Marie-Elisabeth Toubert
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Françoise Bonichon
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Marie Cavarec
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Anne-Marie Bernard
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Andrée Boneu
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Frédéric Leprat
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Oskar Haas
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Christine Lasset
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Martin Schlumberger
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Federico Canzian
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - David E. Goldgar
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| | - Giovanni Romeo
- International Agency for Research on Cancer, Clinique Endocrinologique Nutrition et Diabète, Hôpital de l'Antiquaille, and Unite d'Oncologie Génétique, Centre Léon Bérard, Lyon, France; Royal Hobart Hospital, Hobart, Tasmania, Australia; Dipartimento di Anatomia Patologica, University of Turin, Turin, Italy; Unité de Médecine Nucléaire et Biophysique 2, Institut Jean-Godinot, Reims, France; Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, Nantes, France; Department of Medical Genetics, University of Helsinki, Helsinki; Servizio di Endocrinologia, Arcispedale “S. Maria Nuova,” Reggio Emilia, Italy; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle; Service Central de Médecine Nucléaire, Hôpital Saint Louis, Paris; Service de Médecine Nucléaire, Institut Bergonié, and Endocrinologie et Maladies Métaboliques, Hôpital du Haut-Levêque, Bordeaux, France; Service de Médecine Nucléaire, CHU Morvan, Brest, France; Médecine Nucléaire, Centre Eugène Marquis, Rennes, France; Service de Médecine Nucléaire, Institut Claudius Regaud, Toulouse, France; CCRI, St. Anna Children’s Hospital, Vienna; and Service de Médecine Nucléaire, Institut Gustave Roussy, Villejuif, France
| |
Collapse
|
46
|
le Roux PA, Pahal GS, Hoffman L, Nooh R, El-Refaey H, Rodeck CH. Second trimester termination of pregnancy for fetal anomaly or death: comparing mifepristone/misoprostol to gemeprost. Eur J Obstet Gynecol Reprod Biol 2001; 95:52-4. [PMID: 11267720 DOI: 10.1016/s0301-2115(00)00365-1] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
OBJECTIVE To assess the effect of changing the regimen for second trimester induction of labour from gemeprost to mifepristone/misoprostol. DESIGN AND SETTING A retrospective study at a university teaching hospital over the 5-year period 1993-1997. SUBJECTS, METHODS and REGIMENS: 68 patients, 34 in the gemeprost group and 34 in the mifepristone/misoprostol group. The gemeprost group received 1mg vaginally every 3h to a maximum of five doses. The mifepristone/misoprostol group were pre-treated with 600 mg mifepristone orally followed by 800 microg misoprostol vaginally and then 400 microg orally every 3h to a maximum of four oral doses. MAIN OUTCOME MEASURES Induction to abortion interval; delivery within 24h. RESULTS The mifepristone/misoprostol group had a lower induction to abortion interval compared to the gemeprost group (median 8.9h versus 19.8h, respectively, p<0.01). The mifepristone/misoprostol regimen was more successful than the gemeprost regimen; 94% versus 68%, respectively, aborted without extra medical or surgical intervention, p=0.02. There were no significant differences in side effects, analgesia requirements or complications between the two groups. Three patients with previous Caesarean sections had a ruptured uterus; two from the gemeprost group and one from the mifepristone/misoprostol group. CONCLUSIONS The new mifepristone/misoprostol regimen was more effective in second trimester induction of labour. Induction of labour with misoprostol or gemeprost should be used with care in patients with a previous Caesarean section.
Collapse
Affiliation(s)
- P A le Roux
- Department of Obstetrics and Gynaecology, University College Hospital, London, UK.
| | | | | | | | | | | |
Collapse
|
47
|
Hart DA, Reno C, Hellio Le Graverand MP, Hoffman L, Kulyk W. Expression of heat shock protein 47(Hsp47) mRNA levels in rabbit connective tissues during the response to injury and in pregnancy. Biochem Cell Biol 2001; 78:511-8. [PMID: 11012091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/17/2023] Open
Abstract
Hsp47 (also termed "colligin") is a 47 kDa protein that is localized in the ER and cis-Golgi vesicles of fibrocytes, chondrocytes, and other collagen-secreting cells. Under stress conditions, Hsp47 expression is upregulated as part of the heat shock/stress response that mitigates cell damage from noxious stimuli such as elevated temperature, heavy metals, and oxidative stress. Under non-stress conditions, Hsp47 functions as a collagen-specific molecular chaperone that facilitates intracellular procollagen polypeptide synthesis, and triple helix assembly in connective tissues. Previously it has been shown that levels of collagen-specific gene expression are significantly altered in ligaments, menisci, and other connective tissues of the rabbit following surgically induced injuries (increased), and during pregnancy (decreased). The present study was undertaken to determine whether expression of mRNA for the Hsp47 collagen-binding stress protein was also influenced in these experimental models. Since no sequence information was available on the rabbit Hsp47 gene, a partial cDNA for rabbit Hsp47 was first isolated and cloned using reverse transcriptase PCR (RT-PCR) with degenerate oligonucleotide primers. Rabbit Hsp47 sequence-specific primers then designed enabled analysis of Hsp47 mRNA expression in rabbit connective tissues using semiquantitative RT-PCR. It was found that Hsp47 expression is affected in a complex, tissue-specific manner by injury and pregnancy. Hsp47 transcript levels were elevated in the medial collateral ligament (MCL) of the rabbit knee following surgical induction of a gap injury. Transection of the anterior cruciate ligament (ACL), which leads to chronic progressive damage to menisci of the rabbit knee joint, was accompanied by an upregulation of Hsp47 expression in the medial and lateral menisci. Hsp47 mRNA levels were depressed during pregnancy in the kidney and ACL of primigravid adolescent rabbits, but were not altered in corneal tissue during pregnancy or in the ACL of skeletally mature multiparous females. The changes in Hsp47 transcript levels within these connective tissues following injury/pregnancy often, but not always, paralleled changes in collagen-specific gene expression.
Collapse
Affiliation(s)
- D A Hart
- McCaig Centre for Joint Injury and Arthritis Research, Faculty of Medicine, University of Calgary, AB, Canada
| | | | | | | | | |
Collapse
|
48
|
Abstract
Migraine is a common disorder characterised by recurrent episodes of disability. Despite the high prevalence of migraine, data have been lacking on its impact in a working population. The advent of new therapies has stimulated interest in this area, and evidence is now available that documents the substantial impact of migraine on workplace productivity and the likelihood of untreated migraine leading to unemployment or underemployment for the patient. This paper reviews current findings of both observational and interventional studies about the impact of migraine on productivity and employment. When considered in the light of migraine demographics, the high prevalence of migraine, and its low consultation and treatment rates, this evidence indicates that improved screening and treatment for this common condition could have a substantial impact on worker productivity and on patient well-being.
Collapse
Affiliation(s)
- P Stang
- Galt Associates, Inc., Sterling, Virginia, USA
| | | | | | | |
Collapse
|
49
|
Abstract
An attitude against public presentations has been part of the inward looking stance of organized psychoanalysis and has contributed to the often-heard comment that psychoanalysis is a dying profession. Because of the very private nature of clinical psychoanalytic work, this ambivalence to public appearances continues to exist in all psychoanalysts. We have to realize that it is crucial for psychoanalysts to educate the public about psychoanalytic ideas while being aware of possible unintended negative consequences, such as interference in transference issues with patients, ethical and privacy violations, distortion in the press coverage, unfairly biased antipsychoanalytic coverage, and concern about disapproval from prominent and influential members of psychoanalytic organizations about the nature of the press coverage (or even of press coverage at all) leading to criticism of an individual psychoanalyst and interference with his or her progression. Our public information efforts have to include using misfired efforts as teaching tools and insure that presentation of clinical material is limited and sufficiently disguised.
Collapse
Affiliation(s)
- L Hoffman
- New York Psychoanalytic Institute, USA
| |
Collapse
|
50
|
Andrews JC, Böhmer A, Hoffman L, Strelioff D. Auditory threshold and inner ear pressure: measurements in experimental endolymphatic hydrops. Am J Otol 2000; 21:652-6. [PMID: 10993453] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
Abstract
HYPOTHESIS Experimental endolymphatic hydrops leads to an endolymph-perilymph pressure imbalance that is responsible for the loss of auditory sensitivity in the ear. BACKGROUND This study investigates whether intralabyrinthine pressure is a factor in the auditory dysfunction of experimental endolymphatic hydrops. METHODS Auditory function was investigated in 10 guinea pigs 90 to 120 days after endolymphatic sac ablation by measuring compound action potentials in response to acoustic stimuli including alternating clicks and tone bursts of 0.5, 1, 2, 4, and 8 kHz. After auditory thresholds to the various stimuli were established, endolymphatic and perilymphatic pressures were measured with a no-flow micropressure measuring system. The cause of the hearing loss in Meniere's disease, especially in the early phases of this condition, remains an enigma. Histologic temporal bone preparations show a disproportion in the volume of endolymph to perilymph with an expanded and distorted membranous labyrinth. Speculation as to whether an endolymph-perilymph fluid pressure imbalance is responsible for these morphologic changes were raised by Hallpike and Cairns (1) in their initial report of the histopathology of Meniere's disease. Further speculation has questioned whether this pressure imbalance may be responsible for the symptoms and physical finding of this condition, including hearing loss. The ability to produce experimental endolymphatic hydrops in the guinea pig secondary to surgical occlusion of the endolymphatic sac and duct has been useful in studying various aspects of Meniere's disease (2). Investigators have been able to demonstrate auditory threshold shifts with hydrops. Elevated endolymph-perilymph pressure gradients have also been demonstrated (3). This RESULTS Increased auditory thresholds were noted in the hydrops ears at all tested parameters (p < 0.03). A relative increase in endolymph over perilymph pressure was found in hydrops ears as previously reported. The increase in endolymph-perilymph pressure of hydrops could not be correlated directly to the elevated auditory threshold shift. CONCLUSION Endolymphatic hydrops is a complex pathologic state with multiple inner ear alterations including abnormal intralabyrinthine pressure. Factors other than or in addition to pressure contribute to the auditory threshold shift of hydrops.
Collapse
Affiliation(s)
- J C Andrews
- Division of Head and Neck Surgery, University of California Los Angeles Medical Center, Los Angeles 90095-1624, USA
| | | | | | | |
Collapse
|